Trial record 1 of 5 for:
Insilico Medicine
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05938920 |
|
Recruitment Status :
Recruiting
First Posted : July 11, 2023
Last Update Posted : April 26, 2024
|
Sponsor:
InSilico Medicine Hong Kong Limited
Information provided by (Responsible Party):
InSilico Medicine Hong Kong Limited
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | August 16, 2024 |
| Estimated Study Completion Date : | August 16, 2024 |